New award for glatiramer acetate injections with teva pharmaceuticals USA, INC. Ordering period is august 5, 2023 to august 4, 2024 with four one-year options.
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 36E79723D0023
- Awardee
-
Teva Pharmaceuticals Usa, Inc. UEI NEN9A34LRHJ5
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 6505--Glatiramer Acetate Injections Pre-Solicitation · 36E79723R0012 · Posted Mar 9, 2023
- Last date to order 82% complete
- IDV ceiling
- $64,352,514.80
- Award type
- Single award
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Department of Veterans Affairs National Acquisition Center awarded a single-award indefinite-delivery contract to Teva Pharmaceuticals Usa, Inc. on August 5, 2023, with a ceiling of $64,352,514.80 for glatiramer acetate injections in 20mg/mL and 40mg/mL dosage strengths. The contract extends through August 4, 2027, comprising a one-year base period (August 5, 2023 to August 4, 2024) plus four one-year options.
The solicitation, posted as a pre-solicitation notice on March 9, 2023, sought supply of glatiramer acetate for multiple sclerosis treatment across the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service. Estimated annual requirements total over 208,000 syringes, with pricing evaluated against projected annual quantities of 75,311 syringes of 20mg/mL and 133,346 syringes of 40mg/mL, multiplied by unit prices offered. Offerors were permitted to propose pack sizes of 12 or 30 syringes.
Work is performed at Teva's facility in Parsippany, New Jersey. The NAICS code is 325412 (pharmaceutical preparation manufacturing). This unrestricted procurement carries no set-aside designation and resulted in a single award.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Add Subcontract Plan | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Add Subcontract Plan | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Add Subcontract Plan | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Show all 14
Quick answers
Who was awarded contract 36E79723D0023?
36E79723D0023 was awarded to Teva Pharmaceuticals Usa, Inc. by National Acquisition Center (Headquarters) on August 5, 2023.
How much is contract 36E79723D0023 worth?
36E79723D0023's own ceiling is $64,352,515.
Who can order from contract 36E79723D0023?
36E79723D0023 is a single award indefinite delivery contract.
Was contract 36E79723D0023 competed?
The extent of competition for 36E79723D0023 was full and open competition. The government received 3 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV